Two Sigma Advisers’s OncoSec Medical Incorporated ONCS Stock Holding History

Two Sigma Advisers’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,071	Closed	-$213K	–	3024
2021 Q4	$213K	Sell	10,071 -6,356	-39%	-$215K	﹤0.01%	2269
2021 Q3	$770K	Buy	16,427 +9,227	+128%	+$467K	﹤0.01%	1736
2021 Q2	$445K	Buy	7,200 +2,100	+41%	+$191K	﹤0.01%	1989
2021 Q1	$535K	Buy	5,100 +3,582	+236%	+$490K	﹤0.01%	1996
2020 Q4	$215K	Buy	1,518 +719	+90%	+$76.7K	﹤0.01%	2144
2020 Q3	$59K	Buy	+799	New	+$62.3K	﹤0.01%	2314

Other funds holding ONCS

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Two Sigma Advisers's ONCS Position: Q1 2022 in Review

Two Sigma Advisers sold out of OncoSec Medical Incorporated (ONCS) in Q1 2022, closing a stake of 10,071 shares — an estimated $213K sold.

Two Sigma Advisers first reported a position in ONCS in Q3 2020 and held it in 6 quarters. The position peaked at $770K in Q3 2021. 28 funds tracked by Wall St. Rank hold ONCS as of Q1 2022.

Two Sigma Advisers reported no remaining OncoSec Medical Incorporated position as of Q1 2022 after selling out during the quarter.
Two Sigma Advisers sold 10,071 OncoSec Medical Incorporated shares in Q1 2022, an estimated $213K.
Two Sigma Advisers first reported a position in OncoSec Medical Incorporated in Q3 2020 and held it in 6 quarters.
Two Sigma Advisers's OncoSec Medical Incorporated position peaked at $770K in Q3 2021.
28 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.